Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

Chronic lymphocytic leukemia (CLL) is a form of cancer that leads to an atypically high level of lymphocytes within the bone marrow. Tests, such as a bone marrow biopsy, can determine how advanced CLL ...

When can we answer the question, "Is the treatment working?"After a few courses of treatment for multiple myeloma have passed, many patients likely wonder, "Is this treatment actually working?"The ...

In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones, kidneys, ...

Our body's "blood factory" consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

A new study reveals that stem cell transplants may benefit patients with a rare bone marrow disease, Shwachman-Diamond ...

This study conducted within the phase 3 AML17 and AML19 trials revealed an OS rate of 69% in patients monitored for MRD and 58% in those not monitored. The joint analysis focused on the phase 3 UK ...

Blood tests help doctors detect multiple myeloma by measuring changes in blood cells and proteins associated with bone marrow cancer. A complete blood count (CBC) can show low red blood cells or ...

Want to stay up to date on the latest lab management news? Subscribe to our free Lab Manager Monitor Newsletter. Is the form not loading? If you use an ad blocker or browser privacy features, try ...